Celsus Therapeutics to price public sale of American Depositary Shares

Cowen and Co., Piper Jaffray and MTS Securities assist with financing

By Devika Patel

Knoxville, Tenn., Nov. 20 – Celsus Therapeutics plc said it will conduct a public offering of American Depositary Shares with a 30-day greenshoe. Each ADS represents 10 ordinary shares.

Cowen and Co. and Piper Jaffray are the bookrunning managers. MTS Securities, LLC is the co-manager.

Proceeds will be used to run an MRX-6 phase 2 clinical program in the United States and prepare for the phase 3 program, for development of other product candidates and general corporate purposes.

The New York biotechnology company is developing a new class of non-steroidal, synthetic anti-inflammatory drugs.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.